Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 19/20 | 0.56 |
| ▸ | BCL2 | P10415 | 9/20 | 0.52 |
| ▸ | BCL2L1 | Q07817 | 6/20 | 0.52 |
| ▸ | ALB | P02768 | 3/20 | 0.52 |
| ▸ | BAD | Q92934 | 2/20 | 0.46 |
| ▸ | CDC7 | O00311 | 1/20 | 0.43 |
| ▸ | EEF2K | O00418 | 1/20 | 0.43 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.43 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.43 |
| ▸ | PAK4 | O96013 | 1/20 | 0.43 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.43 |
| ▸ | MARK3 | P27448 | 1/20 | 0.43 |
| ▸ | AXL | P30530 | 1/20 | 0.43 |
| ▸ | AKT2 | P31751 | 1/20 | 0.43 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.43 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.43 |
| ▸ | GSK3B | P49841 | 1/20 | 0.43 |
| ▸ | IRAK1 | P51617 | 1/20 | 0.43 |
| ▸ | NEK2 | P51955 | 1/20 | 0.43 |
| ▸ | NEK4 | P51957 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23753195 | 0.88 | MCL1 (0.52) | MCL1BCL2BCL2L1ALBBAD | |
| SCHEMBL23781448 | 0.80 | BAD (0.50) | MCL1BCL2BCL2L1BAD | |
| SCHEMBL4170406 | 0.79 | MCL1 (0.56) | MCL1BCL2BCL2L1ALBBAD | |
| SCHEMBL23753202 | 0.78 | MCL1 (0.59) | MCL1BCL2BCL2L1ALBBAD | |
| SCHEMBL19615324 | 0.78 | MCL1 (0.66) | MCL1BCL2BCL2L1ALBBAD | |
| SCHEMBL4168839 | 0.74 | MCL1 (0.53) | MCL1BCL2BCL2L1ALBBAD | |
| SCHEMBL29602387 | 0.74 | MCL1 (0.53) | MCL1BCL2BCL2L1ALBBAD | |
| SCHEMBL15622465 | 0.72 | MCL1 (1.00) | MCL1BCL2BCL2L1ALBBAD | |
| SCHEMBL4164201 | 0.72 | MCL1 (0.70) | MCL1BCL2BCL2L1ALBCDC7 | |
| SCHEMBL4161657 | 0.72 | MCL1 (0.72) | MCL1BCL2BCL2L1ALBCDC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11891404-B2 | Substituted macrocyclic indole derivatives | BAYER AKTIENGESELLSCHAFT (DE) | 2024-02-06 | — | — | US | disclosed |
| US-20230112244-A1 | SUBSTITUTED MACROCYCLIC INDOLE DERIVATIVES | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2023-04-13 | — | — | US | disclosed |
| EP-3710456-B1 | MACROCYCLIC INDOLE DERIVATIVES | BROAD INST INC (US) | 2022-09-21 | — | — | EP | disclosed |
| US-11440923-B2 | Substituted macrocyclic indole derivatives | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2022-09-13 | — | — | US | disclosed |
| US-11401278-B2 | Macrocyclic indole derivatives | THE BROAD INSTITUTE, INC. (US) | 2022-08-02 | — | — | US | disclosed |
| US-20210292341-A1 | MACROCYCLIC INDOLE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 2021-09-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230112244-A1 | SUBSTITUTED MACROCYCLIC INDOLE DERIVATIVES | FOXM1, CCND2, CCNI | MCL1 53/4885BCL2 635/4885BCL2L1 715/4885 |
| US-11891404-B2 | Substituted macrocyclic indole derivatives | FOXM1, CCND2, CCNI | MCL1 53/4885BCL2 635/4885BCL2L1 715/4885 |
| US-20210292341-A1 | MACROCYCLIC INDOLE DERIVATIVES | CCND2, CCNA1, CCNT2 | MCL1 56/4885BCL2 741/4885BCL2L1 735/4885 |
| US-11401278-B2 | Macrocyclic indole derivatives | CCND2, CCNA1, CCNT2 | MCL1 56/4885BCL2 741/4885BCL2L1 735/4885 |
| US-11440923-B2 | Substituted macrocyclic indole derivatives | FOXM1, CCND2, CCNI | MCL1 53/4885BCL2 635/4885BCL2L1 715/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.